Company intelligence / Profile preview

Aspect Imaging

Ownership: Private
Development stage: Commercial

Overview

Aspect Imaging’s MRI systems are commercially available and deployed in clinical and preclinical settings. The Embrace® Neonatal MRI System is FDA cleared and CE approved for use at the point-of-care in NICUs. No clinical trial results required as these are diagnostic devices.

Therapeutic areas: OtherNeurology
Modalities: Device (MRI and NMR imaging systems)
Industry: Medical Imaging

Partnerships

Yale University (installation of Embrace® system)Vizient Inc. (Innovative Technology contract)

Beyond the preview

Go deeper on Aspect Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aspect Imaging.

Explore the full profile